|
RPS6KC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
6.84120537997046E-11 |
| Normal-vs-Stage3 |
2.44249065417534E-15 |
| Normal-vs-Stage4 |
1.82887038846502E-12 |
| Stage1-vs-Stage2 |
7.216400E-01 |
| Stage1-vs-Stage3 |
2.572200E-01 |
| Stage1-vs-Stage4 |
6.277700E-02 |
| Stage2-vs-Stage3 |
6.465000E-01 |
| Stage2-vs-Stage4 |
2.153400E-01 |
| Stage3-vs-Stage4 |
3.528800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-16 |
| Normal-vs-AfricanAmerican |
7.79960000000246E-05 |
| Normal-vs-Asian |
2.84490209168098E-11 |
| Caucasian-vs-AfricanAmerican |
9.190200E-02 |
| Caucasian-vs-Asian |
9.720000E-01 |
| AfricanAmerican-vs-Asian |
1.196020E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.10702591327572E-15 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
3.111800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62503344114384E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
4.10782519111308E-12 |
| Normal-vs-Age(81-100Yrs) |
2.602100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.930400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.838200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.145000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.800200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.470600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.043200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.729800E-02 |
| Classical-VS-Follicular |
1.068790E-01 |
| Classical-VS-Other |
1.412410E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
5.349000E-01 |
| Tall-VS-Other |
5.549200E-01 |
| Tall-VS-Normal |
1.35209621276999E-11 |
| Follicular-VS-Other |
3.960200E-01 |
| Follicular-VS-Normal |
1.80200299126909E-12 |
| Other-VS-Normal |
5.92219999999699E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
1.17683640610267E-13 |
| N0-vs-N1 |
2.053400E-01 |
|
|
